Applied DNA Sciences (APDN) Expected to Announce Quarterly Earnings on Thursday

Applied DNA Sciences (NASDAQ:APDN) is expected to issue its Q3 2025 quarterly earnings data before the market opens on Thursday, August 14th. Analysts expect the company to announce earnings of ($37.50) per share and revenue of $1.28 million for the quarter.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings results on Thursday, May 15th. The technology company reported ($230.25) EPS for the quarter, missing analysts’ consensus estimates of ($45.00) by ($185.25). Applied DNA Sciences had a negative net margin of 194.14% and a negative return on equity of 66.95%. The firm had revenue of $0.98 million for the quarter, compared to analyst estimates of $1.19 million.

Applied DNA Sciences Trading Down 4.5%

Shares of APDN stock opened at $4.06 on Wednesday. The business’s 50-day moving average price is $4.87 and its 200-day moving average price is $35.69. Applied DNA Sciences has a 12 month low of $4.04 and a 12 month high of $2,655.00. The firm has a market capitalization of $1.79 million, a price-to-earnings ratio of -0.01 and a beta of -0.02.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Applied DNA Sciences from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.